skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

100+ Total results for product and free and sample content found

Pink Sheet

Global Regulatory Harmonization Discussions Ongoing About COVID-19 Vaccine Boosters

Pfizercovidboostersgreenlightyellowlight

US position remains that boosters are not needed yet, but CBER Director Peter Marks says regulators are discussing how to harmonize applications for booster shots.

Medtech Insight

Carrot’s Pivot Breath Sensor Helps Motivate Smokers To Quit

MT2107_Carrot_pivot_user_1200

Based on the results of a study with 234 smokers, the FDA cleared an updated indication for Carrot’s Pivot breath sensor, an over-the-counter carbon monoxide sensor that helps motivate people to stop smoking.

Medtech Insight

New Guidance On Registration Rules For Importers Into The EU

GB2004_Guidance_592622561_1200

EU rapidly revises new guidance document on registration requirements under the new MDR and IVDR to address question of when importers need to register in Eudamed medical device database.

HBW Insight

With VMS Product Registration 'Inevitable' In US, CRN's OWL Moves 'In Right Direction'

Transparency_keyboard_PXGMY7

Supplement OWL advisory board members Guru Ramanathan and Russ Michelson answer HBW Insight questions about the site’s progress and the potential for mandatory registration for dietary supplements sold in the US.

Scrip

Claims Stream In Under COVAX No-Fault Compensation Program

SC2107_compensationclaims_F3YYB6_1200x675

The WHO indicates that several claim applications have been made under the COVAX no-fault lump-sum compensation program for COVID-19 vaccines. It remains to be seen how the scheme may apply to countries like India, which is also expected to take a call on indemnity to vaccine makers.

Pharma 360

Global Oncology Opportunities & Trends 2025: Key Markets, Indications and Products

Global Oncology Opportunities & Trends 2025

Join Informa Pharma Intelligence for the “Global Oncology Opportunities” webinar! 

Scrip

10 US Approval Decisions To Look Out For In Q3

SC_2107_lioness_2ATXAHM_1200

This quarter has already seen a complete response letter for Iterum Therapeutics’ antibiotic sulopenem but a raft of other products are expecting approval decisions from the US Food and Drug Administration in the next three months. With the help of analysts at Biomedtracker, Scrip takes a look at 10 of the more interesting ones.    

HBW Insight

Perrigo Targets Recyclable Blister Packs In Push To Become 'Genuinely Sustainable'

HBW2105_recyle_2CCB8MK_1200_alamy

“We are actively researching how to be the first OTC pharmaceutical firm to have a blister strip that satisfies regulations that is also recyclable,” reveals Perrigo's sustainability chief Steve Ramus in an exclusive interview with HBW Insight. Ramus also talks about the importance of being genuine when approaching ESG strategy. 

Scrip

Quick Listen: Scrip’s Five Must-Know Things

SC2008_FiveMustKnowThings_1200_Final

In this week's podcast edition of Five Must-Know Things: vaccine efficacy and the Delta and Delta Plus variants; breakthroughs in CRISPR gene editing and microbiome therapies; and the pandemic’s possible effect on regulatory pathways.

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free   : +1 888 670 8900  
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (20) 805 20700

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: